Harbin Medisan Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2020
April 23, 2020 at 04:26 am
Share
Harbin Medisan Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 288.795 million compared to CNY 500.698 million a year ago. Operating income was CNY 39.820 million compared to CNY 67.428 million a year ago. Net income was CNY 31.989 million compared to CNY 53.536 million a year ago. Basic earnings per share from continuing operations was CNY 0.1 compared to CNY 0.17 a year ago.
HARBIN MEDISAN PHARMACEUTICAL CO LTD is a China-based company principally engaged in the research and development, production and sales of chemical preparations, active pharmaceutical ingredients (APIs), medical devices and cosmetics. Its medicines cover the nervous system, cardio-cerebrovascular, systemic anti-infection, musculoskeletal, nutritional infusion, and body fluid balance infusion therapeutic fields. The Company's products include freeze-dried powder injections, small volume injections, large infusion products, solid preparations, medical devices and cosmetics. The Company mainly distributes its products within domestic market.
HARBIN MEDISAN PHARMACEUTICAL CO., LTD. 
